Defunct Company
Total Trials
5
As Lead Sponsor
As Collaborator
0
Total Enrollment
231
NCT00471211
Study Evaluating the Safety, Tolerability and Efficacy of PBT2 in Patients With Early Alzheimer's Disease
Phase: Phase 2
Role: Lead Sponsor
Start: Dec 31, 2006
Completion: Dec 31, 2007
NCT01590888
Effect of PBT2 in Patients With Early to Mid Stage Huntington Disease
Start: Apr 30, 2012
Completion: Feb 28, 2014
NCT02107313
Phase 1 Study to Determine the Effects of Food on the Pharmacokinetic Profile of PBT2
Phase: Phase 1
Start: May 31, 2014
Completion: Jul 31, 2014
NCT02109497
Phase 1 Study to Determine the Effects of PBT2 on the Pharmacokinetic Profile of Caffeine
NCT02249728
Absorption, Metabolism and Excretion Study of [14C]PBT2 and Absolute Bioavailability of PBT2
Start: Jun 30, 2014